Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Neelam Varma

Showing results (231-240 of 253) with videos related to

Pageof 26
Sort By:
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patientsCharanpreet Singh, Nishant Jindal, Padma Youron, et al.
European Journal of Haematology|May 28, 2019
Genetic basis of unexplained erythrocytosis in Indian patientsNabhajit Mallik, Prashant Sharma, Jasbir Kaur Hira, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Annals of Hematology|June 23, 2021
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohortHarpreet Virk, Sonia Rana, Praveen Sharma, et al.
Clinical and Experimental Medicine|July 20, 2023
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemiaDikshat Gopal Gupta, Neelam Varma, Sarki Abba Abdulkadir, et al.
World Journal of Clinical Cases|January 24, 2022
Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitisPankaj Gupta, Gaurav Chayan Das, Akash Bansal, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|October 7, 2021
Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian PatientsDikshat Gopal Gupta, Neelam Varma, Shano Naseem, et al.
Journal of Global Oncology|September 23, 2018
Variation in Adherence Measures to Imatinib TherapyUday Yanamandra, Pankaj Malhotra, K K Sahu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 25, 2020
How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?Arihant Jain, Charanpreet Singh, Rishi Dhawan, et al.
Pageof 26

Showing results (231-240 of 253) with videos related to

Sort By:
Pageof 26
Hematology/Oncology and Stem Cell Therapy|July 6, 2020
Long-term outcomes of innovator versus generic melphalan formulation in autologous hematopoietic cell transplantation for multiple myelomaDeepesh P Lad, Pankaj Malhotra, Amol N Patil, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|April 19, 2021
Efficacy, safety, and quality of life of generic and innovator ibrutinib in Indian CLL patientsCharanpreet Singh, Nishant Jindal, Padma Youron, et al.
European Journal of Haematology|May 28, 2019
Genetic basis of unexplained erythrocytosis in Indian patientsNabhajit Mallik, Prashant Sharma, Jasbir Kaur Hira, et al.
Bone Marrow Transplantation|August 14, 2019
Impact of frailty, melphalan pharmacokinetics, and pharmacogenetics on outcomes post autologous hematopoietic cell transplantation for multiple myelomaRam V Nampoothiri, Kripa Shanker Kasudhan, Amol N Patil, et al.
Annals of Hematology|June 23, 2021
Hematological characteristics, cytogenetic features, and post-induction measurable residual disease in thymic stromal lymphopoietin receptor (TSLPR) overexpressed B-cell acute lymphoblastic leukemia in an Indian cohortHarpreet Virk, Sonia Rana, Praveen Sharma, et al.
Clinical and Experimental Medicine|July 20, 2023
Identification and validation of the optimal reference genes for standardizing the gene expression profiling diagnostic panel of Ph-like B-lineage acute lymphoblastic leukemiaDikshat Gopal Gupta, Neelam Varma, Sarki Abba Abdulkadir, et al.
World Journal of Clinical Cases|January 24, 2022
Value of neutrophil-lymphocyte ratio in evaluating response to percutaneous catheter drainage in patients with acute pancreatitisPankaj Gupta, Gaurav Chayan Das, Akash Bansal, et al.
Turkish Journal of Haematology : Official Journal of Turkish Society of Haematology|October 7, 2021
Characterization of Immunophenotypic Aberrancies with Respect to Common Fusion Transcripts in B-Cell Precursor Acute Lymphoblastic Leukemia: A Report of 986 Indian PatientsDikshat Gopal Gupta, Neelam Varma, Shano Naseem, et al.
Journal of Global Oncology|September 23, 2018
Variation in Adherence Measures to Imatinib TherapyUday Yanamandra, Pankaj Malhotra, K K Sahu, et al.
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|August 25, 2020
How to Use a Prioritised Approach for Treating Hematological Disorders During the COVID-19 Pandemic in India?Arihant Jain, Charanpreet Singh, Rishi Dhawan, et al.
Pageof 26